Japanese rapid/living recommendations on drug management for <scp>COVID</scp> ‐19: updated guidelines (July 2022)-Reference-Cited by-同舟云学术

Japanese rapid/living recommendations on drug management for COVID ‐19: updated guidelines (July 2022)

Published:2022-01 Issue:1 Volume:9 Page:
ISSN:2052-8817
Container-title:Acute Medicine & Surgery
language:en
Short-container-title:Acute Medicine & Surgery

Author:

Yamakawa Kazuma¹^ORCID,Yamamoto Ryo²,Terayama Takero³,Hashimoto Hideki⁴,Ishihara Tadashi⁵,Ishimaru Go⁶,Imura Haruki⁷⁸,Okano Hiromu⁹^ORCID,Narita Chihiro¹⁰^ORCID,Mayumi Takuya¹¹,Yasuda Hideto¹²^ORCID,Yamada Kohei¹³,Yamada Hiroyuki¹⁴^ORCID,Kawasaki Tatsuya¹⁵,Shime Nobuaki¹⁶,Doi Kent¹⁷,Egi Moritoki¹⁸,Ogura Hiroshi¹⁹,Aihara Morio²⁰,Kushimoto Shigeki²¹^ORCID,Nishida Osamu²²,

Affiliation:

1. Department of Emergency and Critical Care Medicine Osaka Medical and Pharmaceutical University Takatsuki Japan

2. Department of Emergency and Critical Care Medicine Keio University School of Medicine Tokyo Japan

3. Department of Psychiatry, School of Medicine National Defense Medical College Tokorozawa Japan

4. Department of Infectious Diseases The University of Tokyo Hospital Tokyo Japan

5. Department of Emergency and Critical Care Medicine Juntendo University Urayasu Hospital Urayasu Japan

6. Department of General Internal Medicine Soka Municipal Hospital Soka Japan

7. Department of Infectious Diseases, Rakuwakai Otowa Hospital Kyoto University Kyoto Japan

8. Department of Health Informatics, School of Public Health Kyoto University Kyoto Japan

9. Department of Critical Care and Emergency Medicine National Hospital Organization Yokohama Medical Center Yokohama Japan

10. Department of Emergency Medicine and Intensive Care Medicine Shizuoka General Hospital Shizuoka Japan

11. Department of Internal Medicine Kanazawa Municipal Hospital Kanazawa Japan

12. Department of Emergency and Critical Care Medicine Jichi Medical University Saitama Medical Center Saitama Japan

13. Department of Traumatology and Critical Care Medicine National Defense Medical College Tokorozawa Japan

14. Department of Primary Care and Emergency Medicine Kyoto University Hospital Kyoto Japan

15. Department of Pediatric Critical Care Shizuoka Children's Hospital Shizuoka Japan

16. Department of Emergency and Critical Care Medicine, Graduate School of Biomedical and Health Sciences Hiroshima University Hiroshima Japan

17. Department of Emergency and Critical Care Medicine, Graduate School of Medicine The University of Tokyo Tokyo Japan

18. Department of Anesthesia Kyoto University Hospital Kyoto Japan

19. Department of Traumatology and Acute Critical Medicine Osaka University Medical School Suita Japan

20. Department of Gastroenterology and Hematology Hirosaki University Graduate School of Medicine Hirosaki Japan

21. Division of Emergency and Critical Care Medicine Tohoku University Graduate School of Medicine Sendai Japan

22. Department of Anesthesiology and Critical Care Medicine Fujita Health University School of Medicine Toyoake Japan

Publisher

Wiley

Subject

Industrial and Manufacturing Engineering,Materials Science (miscellaneous),Business and International Management

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/ams2.789

Reference75 articles.

1. Japanese rapid/living recommendations on drug management for COVID‐19

2. Japanese rapid/living recommendations on drug management for COVID‐19: updated guidelines (September 2021)

3. Development of rapid guidelines: 3. GIN-McMaster Guideline Development Checklist extension for rapid recommendations

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Cytokine storm and translating IL-6 biology into effective treatments for COVID-19;Frontiers of Medicine;2023-12-29

2. Y-site Injection Physical Compatibility of Remdesivir with Select Intravenous Drugs Used in Palliative Care and for Treating Coronavirus Disease 2019;Journal of Nippon Medical School;2023-10-25

3. Phase II, Double-Blinded, Randomized, Placebo-Controlled Clinical Trial Investigating the Efficacy of Mebendazole in the Management of Symptomatic COVID-19 Patients;Pharmaceuticals;2023-05-29

4. Steroid Pulse Therapy as a Treatment for Patients With COVID-19 Pneumonia at an Intensive Care Unit: A Single-Center Retrospective Observational Study;Cureus;2023-03-20

5. Two Years of Experience and Methodology of Korean COVID-19 Living Clinical Practice Guideline Development;Journal of Korean Medical Science;2023